Germ Cell Differentiation from Human Embryonic Stem Cells

生殖细胞从人类胚胎干细胞分化

基本信息

项目摘要

Infertility afflicts approximately 10-15% of couples and has causes linked to all the major events in the reproductive pathways, from development of functional eggs and sperm, to fertilization, embryonic transcriptional activation, implantation, placentation and growth of a viable fetus. In spite of the frequency of infertility and impact on the quality of life of those affected, little is known of underlying molecular and genetic causes. Nonethless, recent advances in assisted reproductive techniques, reproductive biology, human embryonic stem cell (hESC) biology and human genetics, may now allow us to overcome two historicallysignificant limitations in human reproductive studies: namely, the inaccessibility of early human development to biological exploration and the genetic-intractability of the human genome during development. In this proposal, we use the powerful tools of hESC biology and human genetics to test the hypotheses: 1) that multiple members of the DAZ (Deleted in AZoospermia) gene family are required for the formation and/or maintenance of nascent human germ cells and 2) that common genetic variants and unique mutations, enriched in chromosomes of infertile men and women, modulate early human germ cell development in both sexes. Our specific aims are: Aim 1. Define the baseline molecular, temporal and genetic characteristics of differentiation of hESCs and mESCs to the germ cell lineage in vitro and in.vivo. Aim 2. Silence human DAZ, and human and mouse DAZL and BOL genes and assess germ cell development. Aim 3. Examine functional significance of a common variant and a rare mutation in the DAZ gene family in the human population and relate results to human genetic studies and clinical findings. This research is particularly responsive to the health concerns of infertile couples who seek assisted reproductive technologies in hopes of achieving biological parenthood. Indeed, successful completion of the proposed research promises to strengthen our basic understanding of the remarkable pathways by which human germ cells develop, provide useful tools for basic scientists to study human germ cell development, and contribute to the development of novel therapeutics and validated diagnostic genetic tests for clinical use. The research would greatly benefit from the establishment of a center that provides interactions across the community and access to valuable core facilities. This research uses hESC lines from the NIH Registry (UC01, UC06, WA01 and WA09).
不孕症困扰着大约10-15%的夫妇,其原因与世界上所有的重大事件有关。 生殖途径,从功能性卵子和精子的发育,到受精,胚胎 转录激活、着床、胎盘形成和存活胎儿的生长。尽管频率 不孕症和对受影响者生活质量的影响,很少有人知道潜在的分子和遗传 可使.然而,辅助生殖技术的最新进展,生殖生物学,人类 胚胎干细胞(hESC)生物学和人类遗传学,现在可以让我们克服两个历史性的重大 人类生殖研究的局限性:即人类早期发育的不可及性 到生物探索和人类基因组在发育过程中的遗传难题。在这 我们使用hESC生物学和人类遗传学的强大工具来测试假设:1) 需要DAZ(AZoospermia中的DAZ)基因家族的多个成员来形成和/或 维持新生的人类生殖细胞和2)常见的遗传变异和独特的突变, 在不育男性和女性的染色体中富集,调节两者的早期人类生殖细胞发育。 性别我们的具体目标是:目标1。定义基线分子、时间和遗传特征, hESC和mESC在体外和体内分化为生殖细胞谱系。目标2.让人类达兹沉默 以及人和小鼠DAZL和BOL基因,并评估生殖细胞发育。目标3.检查功能 DAZ基因家族中常见变异和罕见突变在人群中的意义, 将结果与人类遗传研究和临床发现联系起来。这项研究特别响应了 寻求辅助生殖技术的不孕夫妇的健康问题, 亲生父母事实上,成功完成拟议的研究有望加强我们的 对人类生殖细胞发育的重要途径的基本了解, 为基础科学家研究人类生殖细胞发育,并有助于开发新的 用于临床用途的治疗剂和经验证的诊断基因测试。这项研究将大大受益于 建立一个中心,提供整个社区的互动和访问有价值的核心 设施本研究使用来自NIH注册的hESC系(UC 01、UC 06、WA 01和WA 09)。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LINDA C GIUDICE其他文献

LINDA C GIUDICE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LINDA C GIUDICE', 18)}}的其他基金

Education - Outreach Core
教育 - 外展核心
  • 批准号:
    10673398
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Leveraging Single-Cell Technologies to Elucidate Niche Environments and Immune Mechanisms Involved in Endometriosis Pathogenesis, Pathophysiology, and Disease Stratification
利用单细胞技术阐明参与子宫内膜异位症发病机制、病理生理学和疾病分层的利基环境和免疫机制
  • 批准号:
    10308248
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement
加州大学旧金山分校斯坦福子宫内膜异位症发现、创新、培训和社区参与中心
  • 批准号:
    10699963
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Leveraging Single-Cell Technologies to Elucidate Niche Environments and Immune Mechanisms Involved in Endometriosis Pathogenesis, Pathophysiology, and Disease Stratification
利用单细胞技术阐明参与子宫内膜异位症发病机制、病理生理学和疾病分层的利基环境和免疫机制
  • 批准号:
    10458758
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement
加州大学旧金山分校斯坦福子宫内膜异位症发现、创新、培训和社区参与中心
  • 批准号:
    10308246
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Administrative Core (Core A)
行政核心(核心A)
  • 批准号:
    10308247
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Administrative Core (Core A)
行政核心(核心A)
  • 批准号:
    10458757
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement
加州大学旧金山分校斯坦福子宫内膜异位症发现、创新、培训和社区参与中心
  • 批准号:
    10458756
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Leveraging Electronic Medical Records and Machine Learning Approaches to Study Endometriosis in Diverse Populations
利用电子病历和机器学习方法研究不同人群的子宫内膜异位症
  • 批准号:
    10771804
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Leveraging Single-Cell Technologies to Elucidate Niche Environments and Immune Mechanisms Involved in Endometriosis Pathogenesis, Pathophysiology, and Disease Stratification
利用单细胞技术阐明参与子宫内膜异位症发病机制、病理生理学和疾病分层的利基环境和免疫机制
  • 批准号:
    10699965
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了